Insider buying
~$360K88K sh @ $4.07
Traded May 27 · filed 2 days later
Since the trade −33.5% · S&P 500 −1.4% · to Nov 16
The CEO of Polaryx Therapeutics paid $360K out of pocket for Polaryx Therapeutics shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
PLYX · NASDAQ · Pharmaceutical Preparations
Polaryx Therapeutics (PLYX) · oqro.io/stocks/PLYX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$1.67−0.10 (−5.65%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
Insider buying
Traded May 27 · filed 2 days later
Since the trade −33.5% · S&P 500 −1.4% · to Nov 16
The CEO of Polaryx Therapeutics paid $360K out of pocket for Polaryx Therapeutics shares.
Insider buying
Traded Feb 18 · filed 2 days later
Since the trade −42.2% · S&P 500 +7.8% · to Nov 16
The CFO of Polaryx Therapeutics paid $8K out of pocket for Polaryx Therapeutics shares.
No earnings release (8-K Item 2.02) is on file for PLYX, so its insider trades cannot be placed against one.